{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-047732","form_type":"8-K","ticker":null,"cik":"0001029142","company_name":"DYNAVAX TECHNOLOGIES CORP","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.739954+00:00","generated_at":"2026-05-25T04:47:05.469873+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Dynavax exchanges $185.3M of 2.5% 2026 notes for $225M 2% 2030 notes plus cash","bullets":["Exchanges ~$185.3M of 2.5% 2026 notes for same principal of 2% 2030 notes plus ~$82.5M cash premium and accrued interest.","Issues ~$39.7M of new 2% 2030 notes for cash; total new notes $225M at 2.00% coupon due March 2030.","Repurchases ~$8M of common stock at $14.01/share in privately negotiated transactions to facilitate the deal.","Approximately $40.2M of 2026 notes remain outstanding with unchanged terms post-closing.","Use of proceeds: cash payment and share repurchases funded by subscription, capped call unwind, and cash on hand."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-047732","json":"https://secwatch.observer/filing/0001193125-25-047732.json","markdown":"https://secwatch.observer/filing/0001193125-25-047732.md","text":"https://secwatch.observer/filing/0001193125-25-047732.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1029142/000119312525047732/0001193125-25-047732-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1029142/000119312525047732/d932746d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T04:47:05.469873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"168b597fac16f79747cc6ae0e586d3b6416ff875","claim":"DYNAVAX TECHNOLOGIES CORP incurred convertible notes of $225.0 million aggregate principal amount at 2.00% per annum maturing March 15, 2030.","evidence_excerpt":"On March 5, 2025, Dynavax Technologies Corporation (the “Company”) entered into privately negotiated exchange and subscription agreements (the “Exchange and Subscription Agreements”) with certain holders of its outstanding 2.50% Convertible Senior Notes due 2026 (the “2026 Notes”) and certain new investors, pursuant to which the Company will issue $225.0 million aggregate principal amount of its 2.00% Convertible Senior Notes due 2030 (the “New Notes”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1029142/000119312525047732/0001193125-25-047732-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$225.0 million aggregate principal amount"},{"label":"Rate","value":"2.00% per annum"},{"label":"Maturity","value":"March 15, 2030"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}